Skip to main content

Peer Review reports

From: A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castration-resistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment

Original Submission
17 May 2020 Submitted Original manuscript
1 Jun 2020 Author responded Author comments - Takashi Kawahara
Resubmission - Version 2
1 Jun 2020 Submitted Manuscript version 2
11 Jun 2020 Reviewed Reviewer Report - Patrick Leo
1 Jul 2020 Reviewed Reviewer Report
9 Jul 2020 Author responded Author comments - Takashi Kawahara
Resubmission - Version 3
9 Jul 2020 Submitted Manuscript version 3
13 Jul 2020 Reviewed Reviewer Report
28 Jul 2020 Reviewed Reviewer Report - Patrick Leo
31 Jul 2020 Author responded Author comments - Takashi Kawahara
Resubmission - Version 4
31 Jul 2020 Submitted Manuscript version 4
6 Aug 2020 Reviewed Reviewer Report
29 Aug 2020 Reviewed Reviewer Report
1 Sep 2020 Reviewed Reviewer Report
8 Sep 2020 Author responded Author comments - Takashi Kawahara
Resubmission - Version 5
8 Sep 2020 Submitted Manuscript version 5
10 Sep 2020 Author responded Author comments - Takashi Kawahara
Resubmission - Version 6
10 Sep 2020 Submitted Manuscript version 6
11 Sep 2020 Author responded Author comments - Takashi Kawahara
Resubmission - Version 7
11 Sep 2020 Submitted Manuscript version 7
Publishing
14 Sep 2020 Editorially accepted
25 Sep 2020 Article published 10.1186/s12885-020-07410-2

You can find further information about peer review here.

Back to article page